or $(0.05) per share, for the three months ended March 31, 2009, compared to a net loss of $2.0 million, or $(0.08) per share, for the same period last year. The lower loss was due to the combination of lower sales and marketing as well as general and administrative expenses in the current quarter coupled with an escrow fund settlement of $2.8 million. As previously announced, the Company settled its claim against the escrow fund established in connection with the July 2006 acquisition of 3e Technologies International, Inc. (3eTI) for approximately $2.8 million, which was reported as a reduction to operating expenses.
"In spite of our business lumpiness and the impact on our projected quarterly revenues, we believe that the combination of our new products, our market focus, as well as our customer relationships should support our growth opportunities in the future," Jalbert added.
The Company's management plans to discuss the financial results and provide an operational progress report on its investor call today at 9:00 a.m. (EDT). The investor conference call will be available via live webcast on the Company's website at www.efjohnsontechnologies.com under the tab "Investor Relations." Investors are advised to go to the website at least 15 minutes prior to the call to register, download and install any necessary audio software. The webcast will be archived for 30 days.
To participate by telephone, the domestic dial-in number is (877) 407-8031 and the international dial-in number is (201) 689-8031. Participants are urged to call in to the conference call at least 10 minutes prior to the start time.
About EF Johnson Technologies, Inc.
Headquartered in Irving, Texas, EF Johnson Technologies, Inc. focuses on innovating, developing and marketing the highest quality secure communications solutions to organizat
'/>"/>
SOURCE EF Johnson Technologies, Inc. Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 Related medicine news :1.
Johnson & Johnson to Participate in Bear Stearns 20th Annual Healthcare Conference2.
Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship3.
Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program4.
Trust for Americas Health Receives $7.6 Million Grant from the Robert Wood Johnson Foundation to Advance the Quality and Impact of the Public Health System5.
Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th6.
Johnson & Johnson Tops Annual Pharmaceutical Company Rankings in a New Report From Industry-Leading Publication Scrip7.
Independence Technology, A Johnson & Johnson Company, Renews Its Contract With Creative Technology Services8.
Johnson & Johnson Launches Global Diabetes Institute to Provide State-of-The- Art Education, Training to Health Professionals9.
Robert Wood Johnson Foundation Announces $15.6 Million Grant to Apply Power of the Archimedes Model to Critical Health Care Decisions10.
UAN Mourns Passing of President Cheryl L. Johnson, RN11.
Johnson & Johnson Pharmaceutical Research & Development Submits New Drug Application for Paliperidone Palmitate